混杂因素控制策略—随机、限制、配对、分层、回归和工具变量法

2016-06-16 MedSci MedSci原创

临床研究的发展可以说是与混杂因素和偏倚的“斗争”密不可分的。临床研究发展到现在,也有很多方法控制混杂因素。混杂控制的水平直接影响到研究的质量!MedSci小编这里把常见的控制混杂的策略全部告诉大家了哦! 随机化 研究对象随机分配于各组,以使比较组之间在混杂因素的分布上达到均衡,常用于实验性研究,以临床实验中多见。可针对已知或未知混杂,但是当样本量较小时,由于机会的原因,可能并不能完全平衡两

临床研究的发展可以说是与混杂因素和偏倚的“斗争”密不可分的。临床研究发展到现在,也有很多方法控制混杂因素。混杂控制的水平直接影响到研究的质量!MedSci小编这里把常见的控制混杂的策略全部告诉大家了哦! 随机化 研究对象随机分配于各组,以使比较组之间在混杂因素的分布上达到均衡,常用于实验性研究,以临床实验中多见。可针对已知或未知混杂,但是当样本量较小时,由于机会的原因,可能并不能完全平衡两组之间的混杂因素,样本量越大,这一问题越小。 RCT在进行分组时,采用完全随机的方法,也就是说每个病例进入病例组和对照组的概率是相同的,这样看得见的和看不见的混杂因素在各组的分布都是均衡的。如果RCT实施过程严格执行随机方案,可以认为只有干预因素在组间是不同的。当然,这仅仅是理论上的。在实际上,RCT时还要考虑分层,区组,以及中心化等一些策略,让随机更有效。 限制 针对某些可能的混杂因素,对研究对象的入选条件加以限制。限制使混杂因素恒定,没有变异,消除了暴露-混杂,疾病-混杂的联系。优点在于概念易懂,然而缺点是符合条件的研究对象减少;筛检大量个体,只能入选其中一部分,这样效率太低;影响结果外推;限制范

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=110393, encodeId=7b4011039352, content=收藏了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af511946360, createdName=1e103005m16(暂无匿称), createdTime=Sat Sep 03 14:57:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101858, encodeId=b2aa1018586b, content=收藏学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b2c1297487, createdName=ghy_happy, createdTime=Sun Aug 21 07:38:00 CST 2016, time=2016-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=96592, encodeId=841196592db, content=好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sun Aug 07 07:02:00 CST 2016, time=2016-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92924, encodeId=2dda929245e, content=学习了,统计好难, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d591737749, createdName=1df0137fm56(暂无匿称), createdTime=Wed Jul 13 10:38:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90124, encodeId=b9719012479, content=说得很细, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Jun 16 20:43:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90125, encodeId=587a90125ae, content=先收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Jun 16 20:43:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90015, encodeId=345d90015cb, content=先收藏,再学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a0b1734764, createdName=土豆, createdTime=Thu Jun 16 13:20:00 CST 2016, time=2016-06-16, status=1, ipAttribution=)]
    2016-09-03 1e103005m16(暂无匿称)

    收藏了。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=110393, encodeId=7b4011039352, content=收藏了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af511946360, createdName=1e103005m16(暂无匿称), createdTime=Sat Sep 03 14:57:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101858, encodeId=b2aa1018586b, content=收藏学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b2c1297487, createdName=ghy_happy, createdTime=Sun Aug 21 07:38:00 CST 2016, time=2016-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=96592, encodeId=841196592db, content=好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sun Aug 07 07:02:00 CST 2016, time=2016-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92924, encodeId=2dda929245e, content=学习了,统计好难, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d591737749, createdName=1df0137fm56(暂无匿称), createdTime=Wed Jul 13 10:38:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90124, encodeId=b9719012479, content=说得很细, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Jun 16 20:43:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90125, encodeId=587a90125ae, content=先收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Jun 16 20:43:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90015, encodeId=345d90015cb, content=先收藏,再学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a0b1734764, createdName=土豆, createdTime=Thu Jun 16 13:20:00 CST 2016, time=2016-06-16, status=1, ipAttribution=)]
    2016-08-21 ghy_happy

    收藏学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=110393, encodeId=7b4011039352, content=收藏了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af511946360, createdName=1e103005m16(暂无匿称), createdTime=Sat Sep 03 14:57:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101858, encodeId=b2aa1018586b, content=收藏学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b2c1297487, createdName=ghy_happy, createdTime=Sun Aug 21 07:38:00 CST 2016, time=2016-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=96592, encodeId=841196592db, content=好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sun Aug 07 07:02:00 CST 2016, time=2016-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92924, encodeId=2dda929245e, content=学习了,统计好难, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d591737749, createdName=1df0137fm56(暂无匿称), createdTime=Wed Jul 13 10:38:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90124, encodeId=b9719012479, content=说得很细, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Jun 16 20:43:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90125, encodeId=587a90125ae, content=先收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Jun 16 20:43:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90015, encodeId=345d90015cb, content=先收藏,再学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a0b1734764, createdName=土豆, createdTime=Thu Jun 16 13:20:00 CST 2016, time=2016-06-16, status=1, ipAttribution=)]
    2016-08-07 1dd96cb3m86(暂无匿称)

    好好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=110393, encodeId=7b4011039352, content=收藏了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af511946360, createdName=1e103005m16(暂无匿称), createdTime=Sat Sep 03 14:57:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101858, encodeId=b2aa1018586b, content=收藏学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b2c1297487, createdName=ghy_happy, createdTime=Sun Aug 21 07:38:00 CST 2016, time=2016-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=96592, encodeId=841196592db, content=好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sun Aug 07 07:02:00 CST 2016, time=2016-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92924, encodeId=2dda929245e, content=学习了,统计好难, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d591737749, createdName=1df0137fm56(暂无匿称), createdTime=Wed Jul 13 10:38:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90124, encodeId=b9719012479, content=说得很细, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Jun 16 20:43:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90125, encodeId=587a90125ae, content=先收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Jun 16 20:43:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90015, encodeId=345d90015cb, content=先收藏,再学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a0b1734764, createdName=土豆, createdTime=Thu Jun 16 13:20:00 CST 2016, time=2016-06-16, status=1, ipAttribution=)]
    2016-07-13 1df0137fm56(暂无匿称)

    学习了,统计好难

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=110393, encodeId=7b4011039352, content=收藏了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af511946360, createdName=1e103005m16(暂无匿称), createdTime=Sat Sep 03 14:57:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101858, encodeId=b2aa1018586b, content=收藏学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b2c1297487, createdName=ghy_happy, createdTime=Sun Aug 21 07:38:00 CST 2016, time=2016-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=96592, encodeId=841196592db, content=好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sun Aug 07 07:02:00 CST 2016, time=2016-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92924, encodeId=2dda929245e, content=学习了,统计好难, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d591737749, createdName=1df0137fm56(暂无匿称), createdTime=Wed Jul 13 10:38:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90124, encodeId=b9719012479, content=说得很细, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Jun 16 20:43:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90125, encodeId=587a90125ae, content=先收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Jun 16 20:43:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90015, encodeId=345d90015cb, content=先收藏,再学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a0b1734764, createdName=土豆, createdTime=Thu Jun 16 13:20:00 CST 2016, time=2016-06-16, status=1, ipAttribution=)]
    2016-06-16 milkshark

    说得很细

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=110393, encodeId=7b4011039352, content=收藏了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af511946360, createdName=1e103005m16(暂无匿称), createdTime=Sat Sep 03 14:57:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101858, encodeId=b2aa1018586b, content=收藏学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b2c1297487, createdName=ghy_happy, createdTime=Sun Aug 21 07:38:00 CST 2016, time=2016-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=96592, encodeId=841196592db, content=好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sun Aug 07 07:02:00 CST 2016, time=2016-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92924, encodeId=2dda929245e, content=学习了,统计好难, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d591737749, createdName=1df0137fm56(暂无匿称), createdTime=Wed Jul 13 10:38:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90124, encodeId=b9719012479, content=说得很细, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Jun 16 20:43:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90125, encodeId=587a90125ae, content=先收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Jun 16 20:43:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90015, encodeId=345d90015cb, content=先收藏,再学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a0b1734764, createdName=土豆, createdTime=Thu Jun 16 13:20:00 CST 2016, time=2016-06-16, status=1, ipAttribution=)]
    2016-06-16 milkshark

    先收藏了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=110393, encodeId=7b4011039352, content=收藏了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af511946360, createdName=1e103005m16(暂无匿称), createdTime=Sat Sep 03 14:57:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101858, encodeId=b2aa1018586b, content=收藏学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b2c1297487, createdName=ghy_happy, createdTime=Sun Aug 21 07:38:00 CST 2016, time=2016-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=96592, encodeId=841196592db, content=好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sun Aug 07 07:02:00 CST 2016, time=2016-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92924, encodeId=2dda929245e, content=学习了,统计好难, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d591737749, createdName=1df0137fm56(暂无匿称), createdTime=Wed Jul 13 10:38:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90124, encodeId=b9719012479, content=说得很细, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Jun 16 20:43:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90125, encodeId=587a90125ae, content=先收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Jun 16 20:43:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90015, encodeId=345d90015cb, content=先收藏,再学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a0b1734764, createdName=土豆, createdTime=Thu Jun 16 13:20:00 CST 2016, time=2016-06-16, status=1, ipAttribution=)]
    2016-06-16 土豆

    先收藏,再学习

    0

相关资讯

如何通过SPSS软件实现随机化过程?

随机过程是临床研究过程中至关重要的一部分。在前面的内容中我们也讲过了很多关于随机和随机数的内容,请大家参阅旧的目录。本期将跟大家一起讨论一下如何通过SPSS来实现随机化过程。 在说之前,先跟大家聊一聊随机数的类型,随机数有真随机数(True Random Number)和伪随机数(Pseudo Random Number)之分。我们平时所使用的无论什么程序产生的随机数都是伪随机数,它是有“种

Ann Rheum Dis:鱼油治疗膝骨关节炎:低剂量足矣

目的:确定在治疗膝骨性关节炎的症状和结构的结果上,高剂量鱼油补充是否优于低剂量。方法:一项随机、双盲、多中心临床试验,纳入202例膝骨关节炎和正常膝关节疼痛患者。他们被随机1:1分为高剂量鱼油组(4.5克omega-3脂肪酸)15毫升/天,低剂量鱼油组(1:9鱼油和葵花油混合,0.45克omega-3脂肪酸)15毫升/天。主要指标是在3,6,12个月和24个月时的西方安大略和麦克马斯特大学骨关节炎

JCO:米非司酮对不可切除的脑膜瘤似乎没什么疗效

70%的脑膜瘤会表达孕激素受体。先前有2期试验结果表明,口服米非司酮对脑膜瘤可起一定疗效作用。研究者进行了一项前瞻性、随机、安慰剂对照的3期试验,探究米非司酮对不可切除的脑膜瘤的疗效。该研究对米非司酮或对照组均进行了2年,除非中途发生了疾病进展。2年后参与者可选择继续当前治疗。研究者对其进行连续随访,评估有效性和毒性。该研究共纳入164名患者,80名接受米非司酮治疗,84名安慰剂治疗。米非司酮组有

随机试验中的样本量考量

普遍的概念认为随机试验需要产生样本量大小相等的各个比较组。这种概念上的误解导致研究者强行达成样本量相等而产生偏倚,尤其如果应用的是不科学的方式。在随机对照试验中,尤其是使用排列区组随机法(permuted-block randomisation) 的非双盲试验(non-douhle-blindedtrials) 中,绝对均等的样本量对提高统计学的把握度没有什么帮助,而且潜在地威胁了不可预测性。

Ann Rheum Dis:阿达木单抗诱导治疗类风湿关节炎的临床和影像学结果

目标:研究1年前经阿达木单抗诱导药治疗的早期类风湿关节炎病人的临床和影像学结局,另加以甲氨蝶呤和关节内糖皮质激素的针对性治疗策略。方法:早期类风湿关节炎病人以改变病情抗风湿药(DMARD)的甲氨蝶呤(20mg每周)与关节内糖皮质激素(20 mg/ml)治疗2年。另外,在第一年随机将他们分配到阿达木单抗诱导安慰剂组(予以单抗诱导安慰剂,n=91)和阿达木单抗诱导组(40 mg每隔一周)(予以阿达木单

随机试验中分配序列的生成与隐藏

随机对照试验提供了临床研究的金标准。随机化首先取决于两个内在相关但彼此独立的步骤,即产生一个不可预测的随机分配序列及隐藏此序列直至分配开始,即为分配隐藏(allocation concealment)。但是,随机化也许是试验中最不容易被理解的部分。任何不恰当的随机化皆导致选择偏倚和混杂偏倚。研究者应摒弃所有非随机的系统性分配方法。受试者的分配入组应为一随机化的过程。 简单(非限制性)随